Live birth rate · women with endometriosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall pain ‐ 3 months · women with endometriosis
1 finding from 1 review
Adverse events · women with endometriosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall pain · women with endometriosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical pregnancy rate · women with endometriosis
It is very uncertain whether pentoxifylline changes clinical pregnancy rate compared with placebo (very low certainty).
1 finding from 1 review
Miscarriage · women with endometriosis
It is very uncertain whether pentoxifylline changes miscarriage rate compared with placebo (very low certainty).
1 finding from 1 review
Recurrence rate of endometriosis · women with endometriosis
It is very uncertain whether pentoxifylline changes recurrence rate of endometriosis compared with placebo (very low certainty).
1 finding from 1 review
Adverse events · women with endometriosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Live birth rate · women with endometriosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall pain ‐ 1 month · women with endometriosis
1 finding from 1 review
Overall pain ‐ 2 months · women with endometriosis
1 finding from 1 review
PFWD (change in metres) (4–40 weeks' · intermittent claudication
1 finding from 1 review
TWD (change in metres) (8–52 weeks' · intermittent claudication
1 finding from 1 review
ABI (pre‐exercise/baseline ABI compared with · intermittent claudication
1 finding from 1 review
QoL · intermittent claudication
1 finding from 1 review
Side effects (number of cases or proportion) (4–52 weeks' · intermittent claudication
1 finding from 1 review
Burning sensation (VAS 0-100) · People of any age with a confirmed diagnosis, by clinical examination and biopsy, of oral submucous fibrosis (OSF)
It is very uncertain whether pentoxifylline changes burning sensation (VAS 0-100) compared with spirulina (very low certainty).
1 finding from 1 review
Maximal mouth opening (interincisal distance) · People of any age with a confirmed diagnosis, by clinical examination and biopsy, of oral submucous fibrosis (OSF)
1 finding from 1 review
Rajendran 2006 (pentoxifylline 14 vs multivitamins 15): reported increased interincisal distance in the pentoxifylline group but no baseline data, so change could not be determined; excluded from meta-analysis.
1 study · 29 participants
GRADE not reported
Difficulty in speech (participant-reported proxy) · People of any age with a confirmed diagnosis, by clinical examination and biopsy, of oral submucous fibrosis (OSF)
Pentoxifylline led to lower difficulty in speech (participant-reported proxy) compared with placebo or no active treatment; GRADE not reported.
1 finding from 1 review
Difficulty in swallowing (participant-reported proxy) · People of any age with a confirmed diagnosis, by clinical examination and biopsy, of oral submucous fibrosis (OSF)
Pentoxifylline led to lower difficulty in swallowing (participant-reported proxy) compared with placebo or no active treatment; GRADE not reported.
1 finding from 1 review